Trevena, Inc. (NASDAQ:TRVN – Get Free Report) shares crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.01 and traded as high as $0.0111. Trevena shares last traded at $0.0111, with a volume of 254 shares traded.
Trevena Trading Up 2,120.0%
The stock has a market cap of $10,644.90, a P/E ratio of -0.00 and a beta of -1.99. The business has a 50-day simple moving average of $0.01 and a 200 day simple moving average of $0.01.
About Trevena
Trevena, Inc is a biopharmaceutical company focused on developing medicines for central nervous system disorders, with an emphasis on addressing the limitations of existing opioid and other neurological therapies. The company was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Trevena’s principal commercial product is OLINVYK (oliceridine) injection, an intravenous opioid approved by the U.S. Food and Drug Administration for the management of acute pain in adults severe enough to require an intravenous opioid analgesic.
Further Reading
- Five stocks we like better than Trevena
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
